ReportsnReports.com: Pet Medications in the U.S.: Prescription and Over-the-Counter Remedies

Oct. 3, 2011 - PRLog -- Seismic shifts are underway in the U.S. market for pet medications as the top veterinary brands of flea/tick spot-ons enter broader distribution; Bayer is leading the way with Advantage and K9 Advantix. At the same time, generic versions of fipronil (the active ingredient in Merial’s Frontline) are coming onto the scene, in some cases resulting in court battles and product withdrawals.

Buy Now: http://www.reportsnreports.com/reports/127884-pet-medications-in-the-us-prescription-and-over-the-counter-re.html

Also upping the ante, major retailers including Walmart and Target are moving into the pet medications space both in store and online, representing new competition to veterinarians and third-party Internet retailers such as PetMed Express. The upshot is increased price pressure, but also potential for an expanded base of purchasers as pet specialty and mass-market retailers create stronger pet health departments centered around formerly vet-only products. Also bolstering market prospects, all of the world’s largest pharmaceutical companies continue to invest in medications for companion animals, often mirroring trends in human medications while targeting the needs of the growing populations of aging and overweight pets.

Bringing in broad perspective from other reports in Packaged Facts’ extensive Pet Medication Market Collection, this report analyzes the market for prescription, over-the-counter, and “ethical” (nonprescription medications whose distribution is restricted by the manufacturer to veterinarians) medications for dogs and cats, with a particular focus on brand-name products used by consumers and on antiparasitics. Retail sales are quantified and projected forward through 2015, and broken out by product type, animal type and retail channel. Despite the lingering impact of the recession, the market outlook remains strong, with U.S. retail sales projected to grow 38% from 2010 to 2015 to reach $9.3 billion. The report provides in-depth coverage of competitive trends and new product trends, and features exclusive consumer data from Packaged Facts’ May-June 2011 Pet Owner Survey. Uniquely cross-tabulated consumer survey results from Experian Simmons provide additional insight into pet medication consumer usage rates, demographics and psychographics.

Browse all Pet Care Reports : http://www.reportsnreports.com

Table of Contents
Chapter 1: Executive Summary
U.S. Retail Sales of Pet Medications at $6.7 Billion in 2011
Competitive Overview
Retail Trends
Consumer Trends
Chapter 2: Market Trends
Market Outlook
Looking Ahead
Chapter 3: Marketing Trends
Focus on Antiparasitics
Trends in Advertising and Promotion
Bayer Study, Fears of Heartworm Resistance Making Waves
Pfizer and Slentrol
Going Natural
Chapter 4: Retail Trends
PetSmart and GNC
Chapter 5: Consumer Trends
Pet Med Psychographics
Appendix: Examples of Consumer Advertising

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com

# # #

ReportsnReports houses a comprehensive online library of more than 50,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites.